← All Sponsors

SPONSOR

Oregon Health and Science University

Total Trials

12

Recruiting

12

Phases

Phase 2, Phase 4

Conditions studied: Suicide Mental Health Issue Corneal Opacity Intellectual Disability Speech and Language Disorder Sleep Cardiovascular Risk Factor Pyoderma Gangrenosum Skin Diseases Wound Heal

Proximal Risk for Suicide in Adolescents

Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Corneal Opacity

Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth

Intellectual Disability

Sleep Duration and Cardiovascular Health

NCT06563323 Phase 2

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Pyoderma Gangrenosum

The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care

Opioid Dependence

Directional Versus Nondirectional DBS for ET

Essential Tremor

Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System

Surgical Wound Infection

NCT06036095 Phase 4

Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study

Neurocognitive Disorders

Bilateral Infant Stimulation Study

Parent-Child Relations

Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

Mild Traumatic Brain Injury, Concussion

Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing

Parkinson Disease